We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Carve-out of Lonza Specialty Ingredients will Help Segment to Become a Global Leader in Microbial Control

Product News   Jun 10, 2019

 
Carve-out of Lonza Specialty Ingredients will Help Segment to Become a Global Leader in Microbial Control

Image credit: Lonza

FURTHER INFORMATION
 
 
 

Related Product News

Advanced BioMatrix Acquires HyStem® from Lineage Cell Therapeutics

Product News

Advanced BioMatrix has acquired the HyStem® line of products, used for making customizable 3D hydrogels, from Lineage Cell Therapeutics.

READ MORE

Horizon Discovery to Provide Access to Novel Base Editing Technology

Product News

Horizon Discovery has announced that it will provide access to a novel base editing technology licensed from Rutgers for exclusive use in therapeutic, diagnostic and services applications.

READ MORE

Horizon Discovery and Mammoth Biosciences Collaborate To Improve Biotherapeutic Production

Product News

Horizon Discovery has signed a collaboration and license agreement with Mammoth Biosciences, to access Mammoth’s novel CRISPR platform and thereby facilitate delivery of a new generation of genetically engineered CHO cells for the production of biotherapeutics.

READ MORE

Like what you just read? You can find similar content on the communities below.

Applied Sciences Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE